Characterization of biological activities of Brucella melitensis lipopolysaccharide

Microbiology and Immunology

Volumn 50, Issue 6, 2006, Pages 421-427

  Tumurkhuu, Gantsetseg ^a   Koide, Naoki ^a   Takahashi, Kazuko ^a   Hassan, Ferdaus ^a   Islam, Shamima ^a   Ito, Hiroyasu ^a   Mori, Isamu ^a   Yoshida, Tomoaki ^a   Yokochi, Takashi ^a  

^a AICHI MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Anti complement activity; Brucella melitensis; Lethality; LPS

Indexed keywords

ENDOTOXIN; LIPOPOLYSACCHARIDE; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; BRUCELLA MELITENSIS; COMPLEMENT INHIBITION; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG ISOLATION; DRUG MECHANISM; ELECTROPHORESIS; ENTEROBACTERIACEAE; ESCHERICHIA COLI; FEMALE; LETHALITY; LIMULUS; MACROPHAGE; MALE; MOUSE; NONHUMAN; SILVER STAINING;

BOS TAURUS; BRUCELLA MELITENSIS; BRUCELLA MELITENSIS 16M; ESCHERICHIA COLI; LIMULUS;

EID: 33745245561     PISSN: 03855600     EISSN: 13480421     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2006.tb03810.x     Document Type: Article

References (39)

1. Bhattacharjee, A.K., van de Verg, L., Izadjoo, M.J., Yuan, L., Hadfield, T.L., Zollinger, W.D., and Hoover, D.L. 2002. Protection of mice against brucellosis by intranasal immunization with Brucella melitensis lipopolysaccharide as a noncovalent complex with Neisseria meningitidis group B outer membrane protein. Infect. Immun. 70: 3324-3329.
2. Campos, M.A., Rosinha, G.M., Almeida, I.C., Salgueiro, X.S., Jarvis, B.W., Splitter, G.A., Qureshi, N., Bruna-Romero, O., Gazzinelli, R.T., and Oliveira, S.C. 2004. Role of Toll-like receptor 4 in induction of cell-mediated immunity and resistance to Brucella abortus infection in mice. Infect. Immun. 72: 176-186.
3. Caroff, M., Bundle, D.R., Perry, M.B., Cherwonogrodzky, J.W., and Duncan, J.R. 1984. Antigenic S-type lipopolysaccharide of Brucella abortus 1119-3. Infect. Immun. 46: 384-388.
4. Caron, E., Peyrard, T., Kohler, S., Cabane, S., Liautard, J.P., and Dornand, J. 1994. Live Brucella spp. fail to induce tumor necrosis factor alpha excretion upon infection of U937-derived phagocytes. Infect. Immun. 62: 5267-5274.
5. Coats, S.R., Reife, R.A., Bainbridge, B.W., Pham, T.T., and Darveau, R.P. 2003. Porphyromonas gingivalis lipopolysaccharide antagonizes Escherichia coli lipopolysaccharide at toll-like receptor 4 in human endothelial cells. Infect. Immun. 71: 6799-6807.
6. Corbel, M.J. 1997. Brucellosis: an overview. Emerg. Infect. Dis. 3: 213-221.
7. Diaz, R., and Oyeledun, M.A. 1977. Studies of some biological activities of "Brucella" endotoxin in normal and infected animals and the role of the hypersensitivity factor. Ann. Sclavo. 19: 117-130.
8. Duenas, A.I., Orduna, A., Crespo, M.S., and Garcia-Rodriguez, C. 2004. Interaction of endotoxins with Toll-like receptor 4 correlates with their endotoxic potential and may explain the proinflammatory effect of Brucella spp. LPS. Int. Immunol. 16: 1467-1475.
9. Ferguson, G.P., Datta, A., Baumgartner, J., Carlson, R.W., and Walker, G.C. 2004. Similarity to peroxisomal-membrane protein family reveals that Sinorhizobium and Brucella BacA affect lipid-A fatty acids. Proc. Natl. Acad. Sci. U.S.A. 101: 5012-5017.
10. Fernandez-Prada, C.M., Nikolich, M., Vemulapalli, R., Sriranganathan, N., Boyle, S.M., Schurig, G.G., Hadfield, T.L., and Hoover, D.L. 2001. Deletion of wboA enhances activation of the lectin pathway of complement in Brucella abortus and Brucella melitensis. Infect. Immun. 69: 4407-4416.
11. Ficht, T.A. 2003. Intracellular survival of Brucella: defining the link with persistence. Vet. Microbiol. 92: 213-223.
12. Godfroid, F., Taminiau, B., Danese, I., Denoel, P., Tibor, A., Weynants, V., Cloeckaert, A., Godfroid, J., and Letesson, J.J. 1998. Identification of the perosamine synthetase gene of Brucella melitensis 16M and involvement of lipopolysaccharide O side chain in Brucella survival in mice and in macrophages. Infect. Immun. 66: 5485-5493.
13. Goldstein, J., Hernandez, D., Frasch, C., Beining, P.R., Betts, M., Hoffman, T., and Golding, B. 1991. Immunogenicity of lipopolysaccharide derived from Brucella abortus: potential as a carrier in development of vaccines for AIDS. Adv. Exp. Med. Biol. 303: 227-233.
14. Goldstein, J., Hoffman, T., Frasch, C., Lizzio, E.F., Beining, P.R., Hochstein, D., Lee, Y.L., Angus, R.D., and Golding, B. 1992. Lipopolysaccharide (LPS) from Brucella abortus is less toxic than that from Escherichia coli, suggesting the possible use of B. abortus or LPS from B. abortus as a carrier in vaccines. Infect. Immun. 60: 1385-1389.
15. Gorvel, J.P., and Moreno, E. 2002. Brucella intracellular life: from invasion to intracellular replication. Vet. Microbiol. 90: 281-297.
16. 15N nitrate in biological fluids. Anal. Biochem. 126: 131-138.
17. Hoffmann, E.M., and Houle, J.J. 1983. Failure of Brucella abortus lipopolysaccharide (LPS) to activate the alternative pathway of complement. Vet. Immunol. Immunopathol. 5: 65-76.
18. Jiang, G.Z., Sugiyama, T., Kato, Y., Koide, N., and Yokochi, T. 1995. Binding of mannose-binding protein to Klebsiella O3 lipopolysaccharide possessing the mannose homopolysaccharide as the O-specific polysaccharide and its relation to complement activation. Infect. Immun. 63: 2537-2540.
19. Jimenez de Bagues, M.P., Dudal, S., Dornand, J., and Gross, A. 2005. Cellular bioterrorism: how Brucella corrupts macrophage physiology to promote invasion and proliferation. Clin. Immunol. 114: 227-238.
20. Jimenez de Bagues, M.P., Gross, A., Terraza, A., and Dornand, J. 2005. Regulation of the mitogen-activated protein kinases by Brucella spp. expressing a smooth and rough phenotype: relationship to pathogen invasiveness. Infect. Immun. 73: 3178-3183.
21. Jones, L.M., and Berman, D.T. 1976. Studies of Brucella lipopolysaccharide. Dev. Biol. Stand. 31: 62-67.
22. Lapaque, N., Moriyon, I., Moreno, E., and Gorvel, J.P. 2005. Brucella lipopolysaccharide acts as a virulence factor. Curr. Opin. Microbiol. 8: 60-66.
23. Leong, D., Diaz, R., Milner, K., Rudbach, J., and Wilson, J.B. 1970. Some structural and biological properties of Brucella endotoxin. Infect. Immun. 1: 174-182.
24. Lopez-Urrutia, L., Alonso, A., Bayon, Y., Nieto, M.L., Orduna, A., and Sanchez Crespo, M. 2001. Brucella lipopolysaccharides induce cyclooxygenase-2 expression in monocytic cells. Biochem. Biophys. Res. Commun. 289: 372-375.
25. Lopez-Urrutia, L., Alonso, A., and Sanchez Crespo, M. 2000. Lipopolysaccharides of Brucella abortus and Brucella melitensis induce nitric oxide synthesis in rat peritoneal macrophages. Infect. Immun. 68: 1740-1745.
26. Lowry, O.H., Rose Brough, N.J., and Randall, R.J. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275.
27. Monreal, D., Grillo, M.J., Gonzalez, D., Marin, C.M., De Miguel, M.J., Lopez-Goni, I., Blasco, J.M., Cloeckaert, A., and Moriyon, I. 2003. Characterization of Brucella abortus O-polysaccharide and lipopolysaccharide mutants and demonstration that a complete core is required for rough vaccines to be efficient against Brucella abortus and Brucella ovis in the mouse model. Infect. Immun. 71: 3261-3271.
28. Moreno, E., and Berman, D.T. 1979. Brucella abortus lipopolysaccharide is mitogenic for spleen cells of endotoxin-resistant C3H/HeJ mice. J. Immunol. 123: 2915-2919.
29. Moreno, E., Berman, D.T., and Boettcher, L.A. 1981. Biological activities of Brucella abortus lipopolysaccharides. Infect. Immun. 31: 362-370.
30. Moreno, E., Pitt, M.W., Jones, L.M., Schurig, G.G., and Berman, D.T. 1979. Purification and characterization of smooth and rough lipopolysaccharides from Brucella abortus. J. Bacteriol. 138: 361-369.
31. Schurig, G.G., Roop, R.M., Bagchi, T., Boyle, S., Buhrman, D., and Sriranganathan, N. 1991. Biological properties of RB51; a stable rough strain of Brucella abortus. Vet. Microbiol. 28: 171-188.
32. Spellman, J.M., and Reed, N.D. 1979. Immune and mitogenic responses by BALB/c, C3H/HeJ, and nude mice to Brucella abortus bacterin and lipopolysaccharide. Infect. Immun. 24: 371-378.
33. Takahashi, K., Morikawa, A., Kato, Y., Sugiyama, T., Koide, N., Mu, M.M., Yoshida, T., and Yokochi, T. 2001. Flavonoids protect mice from two types of lethal shock induced by endotoxin. FEMS Immunol. Med. Microbiol. 31: 29-33.
34. Tsai, C.M., and Frasch, C.E. 1982. A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels. Anal. Biochem. 119: 115-119.
35. Tsukushi, Y., Kido, N., Saeki, K., Sugiyama, T., Koide, N., Mori, I., Yoshida, T., and Yokochi, T. 2004. Characteristic biological activities of lipopolysaccharides from Sinorhizobium and Mesorhizobium. J. Endotoxin Res. 10: 25-31.
36. Westphal, O., and Jann, K. 1965. Bacterial lipopolysaccharides-extraction with phenol water and further application of the procedure. Methods Carbohydr. Chem. 5: 83-91.
37. Wu, A.M., and Mackenzie, N.E. 1987. Structural and immunochemical characterization of the O-haptens of Brucella abortus lipopolysaccharides from strains 19 and 2308. Mol. Cell. Biochem. 75: 103-111.
38. Yokochi, T., Inoue, Y., Kimura, Y., and Kato, N. 1990. Strong interaction of lipopolysaccharides possessing the mannose homopolysaccharides with complement and its relation to adjuvant action. J. Immunol. 144: 3106-3110.
39. Yokochi, T., Inoue, Y., Yokoo, J., Kimura, Y., and Kato, N. 1989. Retention of bacterial lipopolysaccharide at the site of subcutaneous injection. Infect. Immun. 57: 1786-1791.